003000 — Bukwang Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Market Cap
KR₩405bn
Enterprise Value
KR₩341bn
Revenue
KR₩126bn

Annual balance sheet for Bukwang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37,585	89,591	84,277	85,517	151,227
Net Total Accounts Receivable
Net Total Receivables	103,974	106,348	95,550	93,045	45,041
Total Inventory
Prepaid Expenses
Total Current Assets	186,398	248,209	220,095	218,741	254,179
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	128,809	106,298	124,531	123,960	122,789
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	388,535	400,969	397,417	400,929	429,017
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35,884	61,204	36,995	44,603	97,544
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	62,288	142,470	127,809	137,712	202,706
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	326,246	258,499	269,608	263,217	226,311
Total Liabilities & Shareholders' Equity	388,535	400,969	397,417	400,929	429,017
Total Common Shares Outstanding